The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Agafonov B.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Podrezova L.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Karavashkina E.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Vishniakova T.I.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Smirnova L.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Dadasheva M.N.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Shevtsova N.N.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Treatment of patients with movement and cognitive disorders in the residual period of stroke

Authors:

Agafonov B.V., Podrezova L.A., Karavashkina E.A., Vishniakova T.I., Smirnova L.A., Dadasheva M.N., Shevtsova N.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(12‑2): 55‑58

Views: 1824

Downloaded: 31

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Agafonov BV, Podrezova LA, Karavashkina EA, Vishniakova TI, Smirnova LA, Dadasheva MN, Shevtsova NN. Treatment of patients with movement and cognitive disorders in the residual period of stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(12‑2):55‑58. (In Russ.)

 
МСФ на ЯМ
Close metadata
Recommended articles:
Cere­brolysin as an early add-on to repe­rfusion therapy: hete­rogeneous treatment effect analysis in ischemic stroke patients with varying risk of hemo­rrhagic transformation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):55-66
Effi­cacy of Mexi­dol in combination with cere­bral reva­scularization in the treatment of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3-2):67-74
Cognitive impairment in cere­brovascular diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):12-16
Algo­rithms for the diagnosis and treatment of cognitive impairment and dysphagia in stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):100-107
Brain-derived neurotrophic factor in the acute and early reco­very period of ischemic stroke: the role of nocturnal hypo­xemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5-2):72-78
Comparison of the effe­ctiveness of non-immunogenic staphylokinase and alte­plase for intravenous thro­mbolysis in ischemic stroke: analysis of hospital regi­stry data. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):139-144
Arti­ficial ventilation in patients with stroke: main resu­lts of the Russian multicenter obse­rvational clinical trial RETAS. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):5-13
The impact of the impairment of social cognitive functions in acute stage of stroke on its functional outcomes. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):21-25
Possibilities of mirror therapy in cognitive reha­bilitation after stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):64-71
Dyna­mics of motor and functional diso­rders in the early reco­very period after ischemic stroke. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):13-22

The efficacy and safety of axamon was studied in a trial with parallel groups in patients, aged 65-88 years, with movement and cognitive disorders in the residual period of stroke. Twenty-five patients received basic therapy and 25 patients were treated with axamon as an add-on drug in dosage of 20 mg 3 times a day during 12 weeks. Along with the neurological examination, a battery of neuropsychological scales and tests was used. The reduction of cognitive and movement deficits was observed. Axamon promotes the optimization of restoration potential of patients in the residual period of stroke.

Keywords:

stroke
axamon

Authors:

Agafonov B.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Podrezova L.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Karavashkina E.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Vishniakova T.I.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Smirnova L.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Dadasheva M.N.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Shevtsova N.N.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

List of references:

  1. Gusev E.I., Skvortsova V.I. Ishemiya golovnogo mozga. M 2001.
  2. Gusev E.I. Problema insul'ta v Rossii. Insul't 2003;9 (prilozhenie k Zhurnalu nevrologii i psikhiatrii).
  3. Putilina M.V. Khronicheskaya ishemiya mozga. Lechashchii vrach 2005;6:28-33.
  4. Gekht A.B. Ishemicheskii insul't: vtorichnaya profilaktika i osnovnye napravleniya farmakoterapii v vosstanovitel'nom periode. Consilium Medicum 2001;3:5.
  5. Damulin I.V., Parfenov V.A., Skoromets A.A., Yakhno N.N. Narusheniya krovoobrashcheniya v golovnom i spinnom mozge. V kn.: Bolezni nervnoi sistemy. Rukovodstvo dlya vrachei. M: Meditsina 2003;274-291.
  6. Damulin I.V. Distsirkulyatornaya entsefalopatiya: patogenez, klinika, lechenie. Metod. rekomendatsii. M 2005;48.
  7. Damaerschalck B.M., Winqerchuk D.M. Treatment of vascular dementia and vascular cognitive impairment. Neuroloqist 2007;13:1:37-41.
  8. Erkinjuntti T., Roman G., Gauthier S. et al. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 2004;35:1010-1017.
  9. Gavrilova S.I. Farmakoterapiya bolezni Al'tsgeimera. M: Pul's 2003;109-115.
  10. Katunina E.A. Primenenie ipidakrina v vosstanovitel'nom periode ishemicheskogo insul'ta. Rus med zhurn 2008;16:12:1633.
  11. Allain H., Bentue-Firrer D., Belliard S. et al. Mild cognitive impairment: potentia therapeutics. Rev Neurol (Paris) 2002;158:10:35-40.
  12. Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev 2006.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.